...
首页> 外文期刊>Medicine. >The efficacy of dexamethasone on pain and recovery after total hip arthroplasty: A systematic review and meta-analysis of randomized controlled trials
【24h】

The efficacy of dexamethasone on pain and recovery after total hip arthroplasty: A systematic review and meta-analysis of randomized controlled trials

机译:地塞米松对总髋关节置换术后疼痛和恢复的疗效:随机对照试验的系统评价和荟萃分析

获取原文
           

摘要

Background: Total hip arthroplasty (THA) perioperative dexamethasone treatment is still a controversial subject. We write this systematic review and meta-analysis to evaluate the efficacy of dexamethasone on pain and recovery after THA. Methods: Two researchers searched the relevant studies from Pubmed, Cochrane, and Embase. The research was reported according to the preferred reporting items for systematic reviews and meta-analysis (PRISMA) guidelines. Randomized controlled trials (RCTs) were included in our meta-analysis . At the same time, the assessment of the risk of bias was conducted according to the Cochrane Handbook for Systematic Reviews of Interventions version. The pooled data are processed by software RevMan 5.3. Result: In accordance with inclusion and exclusion, 3 studies with 207 patients were eligible and accepted into this meta-analysis . For RCTs, the risk of bias was evaluated by Cochrane Collaboration tool. Only one study did not have detection bias. Our study demonstrated that the dexamethasone group was more effective than the placebo group in term of visual analogue scale (VAS) score at 24 hours ( P < .001), 48 hours ( P = .04); opioid consumption ( P < .001); length of stay (LOS, P < .001); and postoperative nausea ( P = .001). Conclusion: Dexamethasone not only reduces postoperative pain scores and postoperative opioids consumption within 48 hours, but also reduces postoperative vomiting and effectively reduces LOS. However, we still need large sample size and high quality studies to explore the relationship between complications and dose response to give the final conclusion.
机译:背景:总髋关节置换术(THA)围手术期地塞米松治疗仍然是一个有争议的主题。我们编写了该系统审查和荟萃分析,以评估地塞米松对THA后疼痛和恢复的疗效。方法:两位研究人员从PubMed,Cochrane和Embase中搜索了相关研究。该研究报告了根据系统评价和荟萃分析(PRISMA)指南的首选报告项目。随机对照试验(RCT)包含在我们的META分析中。与此同时,根据Cochrane手册进行偏见风险的评估,用于系统性审查的干预措施版本。汇总数据由软件Revman 5.3处理。结果:按照包含和排斥,3例患者的3项研究符合条件并接受该荟萃分析。对于RCT,通过Cochrane协作工具评估偏差的风险。只有一项研究没有检测偏差。我们的研究表明,在24小时(P <0.001),48小时(P = .04),地塞米松组比视觉模拟量表(VAS)评分的术语更有效。阿片类药物消费(P <.001);逗留时间(LOS,P <.001);和术后恶心(p = .001)。结论:地塞米松不仅减少了术后疼痛评分和术后48小时内消费,而且还减少了术后呕吐,有效地减少了洛杉矶。然而,我们仍然需要大的样本量和高质量的研究,以探讨并发症与剂量反应之间的关系,以获得最终结论。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号